Tumor News and Research

RSS

Thyroid tumors may be more susceptible to precisely targeted radiation treatment, suggests study

Anaplastic thyroid cancer is almost uniformly fatal, with an average lifespan of about 5 months after diagnosis.

22 May 2018

Higher body temperatures speed the bodies' responses to infections and tumors, finds research

The hotter our body temperature, the more our bodies speed up a key defense system that fights against tumors, wounds or infections, new research by a multidisciplinary team of mathematicians and biologists from the Universities of Warwick and Manchester has found.

21 May 2018

Researchers create tool to determine patient's response to immunotherapy drugs

Understanding that not all bladder cancers are the same, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center have created a tool that may help them to uncover why only a fraction of patients respond to new immune-based treatments.

21 May 2018

New case report reveals negative clinical impact of using biotin supplement

A new case report in the Journal of the Endocrine Society documents how a patient's use of a common biotin supplement, also known as vitamin B7, caused her to have clinically misleading test results, which prompted numerous consultations and unnecessary radiographic and laboratory testing.

21 May 2018

When is insurance not really insurance? When you need pricey dental care.

I'm 61 years old and a San Francisco homeowner with an academic position at the University of California-Berkeley, which provides me with comprehensive health insurance. Yet, to afford the more than $50,000 in out-of-pocket expenses required for the restorative dental work I've needed in the past 20 years, I've had to rely on handouts — from my mom.

21 May 2018

Researchers use MR spectroscopy to investigate mechanisms behind targeted treatment for gliomas

Using a novel imaging method, a Massachusetts General Hospital research team is investigating the mechanisms behind a potential targeted treatment for a subtype of the deadly brains tumors called gliomas.

21 May 2018

ABPI expert urges to find new 'blockbuster treatments' for brain tumors

Nearly 11,500 people are diagnosed with a brain tumor every year in the UK with fewer than 15% surviving beyond 10 years. This week’s announcement from the from the Department of Health and Social Care – following the death of Dame Tessa Jowell - that they would be doubling investment for brain cancer research to £40 million is a welcome commitment to helping achieve a goal our industry shares: finding innovative new treatments and cures for these diseases.

21 May 2018

Novel IR imaging offers rapid and reliable analysis of cancer tissues

Researchers at Ruhr-Universität Bochum have deployed a novel infrared (IR) microscope with quantum cascade lasers in order to analyze tissue samples taken during routine clinical procedures for colorectal cancer diagnosis.

From Daylight Solutions Inc 18 May 2018

Study offers novel solution to suppress metastatic spread of deadly breast cancer

USC researchers have pinpointed a remedy to thwart a protein that helps the metastatic spread of breast cancer, a leading cause of death for women. The findings appear today in Nature Communications.

18 May 2018

KARL STORZ launches new PDD Blue Cystoscopy system for enhanced detection of NMIBC tumors

KARL STORZ Endoscopy-America, Inc., announces the commercial launch of the PDD Blue Light Flexible Video Cystoscopy System for enhanced detection of non-muscle invasive bladder cancer.

18 May 2018

Study: Psoriasis patients taking Humira show no change in aortic inflammation

An antibody used to treat the skin disease psoriasis and other chronic autoimmune diseases such as rheumatoid arthritis and inflammatory bowel disease has no effect on aortic inflammation – a key marker of future risk of major cardiovascular events – unlike other antibodies that target different aspects of the immune system.

18 May 2018

New blood test shows promise for early detection of pancreatic cancer

Pancreatic cancer is expected to become the second deadliest cancer in the United States by 2030. It is tough to cure because it is usually not discovered until it has reached an advanced stage. But a new diagnostic test developed by researchers at UC San Diego shows promise for detecting the disease earlier.

17 May 2018

Pancreatic cancer patients with BRCA1 or BRCA2 mutations fare better on platinum-based chemotherapy

A small study of adults with the most common form of pancreatic cancer adds to evidence that patients with BRCA1 or BRCA2 gene mutations long linked to a high risk of breast cancer have poorer overall survival rates than those without the mutations.

17 May 2018

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Pfizer Inc. announced today positive top-line results of a Phase 3 study examining the use of LYRICA® Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four years of age.

17 May 2018

Scientists discover how unusually long strands of RNA help colon cancer cells avoid death

Researchers from Case Western Reserve University School of Medicine have discovered how unusually long strands of RNA help colon cancer cells avoid death, allowing unregulated growth.

17 May 2018

Researchers discover medulloblastoma subtype that responds to less aggressive therapy

The youngest patients with the brain tumor medulloblastoma are among the most challenging because their rapidly developing brains limit treatment options.

17 May 2018

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Alexo Therapeutics, a clinical-stage immuno-oncology company developing therapies to block the CD47 checkpoint mechanism, today announced it has initiated ALX148 combination dosing with targeted antibody therapies in its Phase 1 clinical program in patients with advanced solid tumors and lymphoma.

17 May 2018

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.

17 May 2018

AstraZeneca collaborates with Emulate to integrate Organs-on-Chips technology into drug development labs

Emulate, Inc. has formed a collaborative partnership with AstraZeneca’s Innovative Medicines and Early Development Biotech Unit to embed its Organs-on-Chips technology within the laboratories of the IMED Drug Safety organization.

From AstraZeneca 17 May 2018

New mode of proton therapy for lung cancer developed by Beaumont shows promising results

"Beaumont researchers have invented a new mode of proton therapy for lung cancer," said Peyman Kabolizadeh, M.D., Ph.D., clinical director, Beaumont Proton Therapy Center in Royal Oak.

17 May 2018

Tumor News and Research

Thyroid tumors may be more susceptible to precisely targeted radiation treatment, suggests study

Higher body temperatures speed the bodies' responses to infections and tumors, finds research

Researchers create tool to determine patient's response to immunotherapy drugs

New case report reveals negative clinical impact of using biotin supplement

When is insurance not really insurance? When you need pricey dental care.

Researchers use MR spectroscopy to investigate mechanisms behind targeted treatment for gliomas

ABPI expert urges to find new 'blockbuster treatments' for brain tumors

Novel IR imaging offers rapid and reliable analysis of cancer tissues

Study offers novel solution to suppress metastatic spread of deadly breast cancer

KARL STORZ launches new PDD Blue Cystoscopy system for enhanced detection of NMIBC tumors

Study: Psoriasis patients taking Humira show no change in aortic inflammation

New blood test shows promise for early detection of pancreatic cancer

Pancreatic cancer patients with BRCA1 or BRCA2 mutations fare better on platinum-based chemotherapy

Pfizer announces Phase 3 study results of LYRICA Oral Solution CV for pediatric epilepsy patients

Scientists discover how unusually long strands of RNA help colon cancer cells avoid death

Researchers discover medulloblastoma subtype that responds to less aggressive therapy

Alexo Therapeutics marks next significant milestone by initiating ALX148 combination cohorts

Obsidian Therapeutics presents preclinical data on regulated IL12 and IL15 programs

AstraZeneca collaborates with Emulate to integrate Organs-on-Chips technology into drug development labs

New mode of proton therapy for lung cancer developed by Beaumont shows promising results

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News